A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma
Open Access
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (1) , 113-114
- https://doi.org/10.1023/a:1008386822906
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomesCancer Chemotherapy and Pharmacology, 1999
- Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trialsAnnals of Oncology, 1997
- Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trialCancer, 1988